| Literature DB >> 24003033 |
Florian Heigwer1, Grainne Kerr, Nike Walther, Kathrin Glaeser, Oliver Pelz, Marco Breinig, Michael Boutros.
Abstract
Use of transcription activator-like effector nucleases (TALENs) is a promising new technique in the field of targeted genome engineering, editing and reverse genetics. Its applications span from introducing knockout mutations to endogenous tagging of proteins and targeted excision repair. Owing to this wide range of possible applications, there is a need for fast and user-friendly TALEN design tools. We developed E-TALEN (http://www.e-talen.org), a web-based tool to design TALENs for experiments of varying scale. E-TALEN enables the design of TALENs against a single target or a large number of target genes. We significantly extended previously published design concepts to consider genomic context and different applications. E-TALEN guides the user through an end-to-end design process of de novo TALEN pairs, which are specific to a certain sequence or genomic locus. Furthermore, E-TALEN offers a functionality to predict targeting and specificity for existing TALENs. Owing to the computational complexity of many of the steps in the design of TALENs, particular emphasis has been put on the implementation of fast yet accurate algorithms. We implemented a user-friendly interface, from the input parameters to the presentation of results. An additional feature of E-TALEN is the in-built sequence and annotation database available for many organisms, including human, mouse, zebrafish, Drosophila and Arabidopsis, which can be extended in the future.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24003033 PMCID: PMC3814377 DOI: 10.1093/nar/gkt789
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.E-TALEN workflow. The E-TALEN workflow can be divided into three parts: the web service/interface, the implemented design algorithm and the output in various file formats and an html report. The web service can be sub-divided into the two different aims of de novo design of TALENs against a specific target and the re-evaluation of existing TALENs to find/re-check their target or genomic context. Depicted on the right are the pre-calculated databases that supply the design algorithm with genomic or sequence information, enabling fast and efficient information management during the design procedure. The main part of E-TALEN consists of design algorithms that find and validate putative TALEN targets, followed by providing comprehensive information on resulting TALENs and their target sites. These two parts of the workflow are hidden from the user. The last part of the E-TALEN workflow is the generation of an output that comprises various computer and human-readable file formats, which are known from high-throughput sequencing, and a visual report shown in the user’s browser.
TALEN designs targeting the second exon of Pten in different organisms
| Gene sequence length (bp) | 108817 | 23926 | 4730 |
| Number of all possible designs | 9052 | 1997 | 370 |
| Number of designs failing by sequence composition | 5059 | 924 | 170 |
| Number of designs failing because not hitting a gene | 0 | 0 | 0 |
| Number of designs failing because not hitting an exon | 3598 | 920 | 51 |
| Number of designs that fails because targeting in a CpG island | 34 | 30 | 0 |
| Number of designs that does not hit the specific exon number 1 | 326 | 94 | 115 |
| Number of designs that does hit multiple target sites | 8 | 0 | 0 |
| Number of designs that result after all filtering | 27 | 29 | 34 |
TALENs were designed with the purpose of introducing a DSB in the second exon of Pten in H. sapiens, D. melanogaster and D. rerio. Here, designs were considered valid if they target any second exon regardless of the transcript. All design criteria were applied sequentially, and TALENs not passing were excluded from further assessments. (Parameters: minimum tale length = maximum tale length = 18 RVDs, minimum spacer length = maximum spacer length = 15 bp, exclude all unfavoured regions).
Figure 2.TALEN design output with exon 2 of Pten in different organisms as target. TALENs were designed against the tumour suppressor gene Pten with the aim to target the second exon. Shown are independent design runs for the three organisms human, zebrafish and fruit fly. Different transcripts of the gene are coloured orange, different coding sequences are coloured light green and TALENs are shown in yellow. Note that a TALEN is considered valid if any transcript’s second exon is targeted. Targeting the second exon is likely to introduce knockout mutations in the Pten gene.